Drugs / PF-04991532
Trials 11 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 19 trials | ||||||
| Phase 1 | NCT01469065 | Dec 2011 → May 2012 | type 2 diabetes mellitus | Pfizer | Completed | No outcome recorded |
| Phase 1 | NCT01469481 | Nov 2011 | — | Pfizer | Completed | No outcome recorded |
| Phase 1 | NCT01369602 | Jul 2011 → Feb 2012 | type 2 diabetes mellitus | Pfizer | Completed | No outcome recorded |
| Phase 1 | NCT01370343 | Jul 2011 | — | Pfizer | Completed | No outcome recorded |
| Phase 1 | NCT01388829 | Jul → Aug 2011 | — | Pfizer | Completed | No outcome recorded |
| Phase 1 | NCT01369277 | Jun → Sep 2011 | type 2 diabetes mellitus | Pfizer | Completed | No outcome recorded |
| Phase 1 | NCT01351129 | May → Jun 2011 | — | Pfizer | Completed | No outcome recorded |
| Phase 1 | NCT01129258 | Jun → Dec 2010 | type 2 diabetes mellitus | Pfizer | Completed | No outcome recorded |
| Phase 1 | NCT01102673 | Apr → Jun 2010 | type 2 diabetes mellitus | Pfizer | Completed | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT01338870 | Jun 2011 → Mar 2012 | type 2 diabetes mellitus | Pfizer | Completed | No outcome recorded |
| Phase 2 | NCT01336738 | Jun 2011 → Mar 2012 | type 2 diabetes mellitus | Pfizer | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 12 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-04991532 | “A Phase 1, Single-Dose, Open-Label, Crossover Study To Assess The Relative Bioavailability Of 2 Different Formulations Of PF-04991532” NCT01388829 ↗10“Single Dose Study To Compare Pharmacokinietics Of 3 Different Formulations Of PF-04991532 In Healthy Volunteers” NCT01351129 ↗ |
| Action | Activate | “Hexokinase type IV activator” CHEMBL2165620 ↗ |
| Modality | Small molecule | — CHEMBL2165620 ↗ |
| Route | Oral | “single escalating oral doses” NCT01102673 ↗ |
| Target | GCK | “Hexokinase type IV activator” CHEMBL2165620 ↗ |